Fat Science
What if the scale isn't moving, but your health is dramatically improving?
If you've ever felt discouraged because the number on the scale won't budge—even on a GLP-1 medication—this episode will change how you think about these drugs. Dr. Cooper breaks down the research showing that the biggest benefits have nothing to do with weight loss. It's all about metabolic health.
This Week on Fat Science
Dr. Emily Cooper, Mark Wright, and Andrea Taylor expl
info_outlineFat Science
This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor answer listener mailbag questions from California, the UK, France, Washington, Wyoming, and beyond.
The team breaks down why Dr. Cooper does not recommend calorie tracking (and when limited tracking can make sense), how to build confidence in eating without data, and why “mechanical eating” sometimes needs medical customization—especially for people with slow gut transit or gastroparesis-like symptoms.
info_outlineFat Science
his week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor answer listener mailbag questions that get to the heart of metabolic health. The team explains the real difference between meals and snacks, discusses whether GLP-1 medications can be appropriate for children in complex cases, explores why some people appear to be “non-responders” to Wegovy, and breaks down why alarming headlines about rapid weight regain miss the bigger metabolic picture. They also explain how to set
info_outlineFat Science
This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor break down two GLP-1 studies that challenge a major media myth: GLP-1 medications don’t drive weight loss just because people eat less. Instead, drugs like tirzepatide and semaglutide create direct metabolic shifts—including increased fat oxidation and improved fuel partitioning—regardless of appetite.
The team also explores mechanical eating, the psychological impact of “diet food,” and Andrea’s 13-yea
info_outlineFat Science
This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor tackle a wide-ranging mailbag episode with listener questions from the U.S., UK, and Europe. Topics include unexpected weight regain on GLP-1s, post-meal sleepiness and hypoglycemia, metabolic dysfunction despite normal labs, GLP-1 dosing strategies, and why these medications are about metabolism, not appetite suppression.
Key Questions Answered
- Why can weight regain happen on info_outline
Fat Science
This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor talk with pediatric eating disorder specialist Dr. Julie O’Toole (Kartini Clinic) and pediatric obesity expert Dr. Evan Nadler about what childhood obesity really is: a biologic, metabolic disease—not a willpower problem and not a failure of parenting.
They explore how excess weight, constant hunger, and disordered eating in kids are often signs of underlying metabolic dysfunction and genetics—and why the old
info_outlineFat Science
This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor talk with exercise physiologist Russell Cunningham and patient Becca Wert about a counterintuitive reality: for some people, exercise can actually slow metabolism, stall weight loss, and trigger weight gain—especially when the brain senses a threat to energy availability.
Dr. Cooper explains how overtraining, under-fueling, and even thinking about workouts can activate famine signals in the brain and shut down
info_outlineFat Science
This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor unpack the biggest GLP-1 headlines from around the world—from the World Health Organization’s first-ever GLP-1 obesity guidelines to access battles, brain research, and the coming wave of generics and new meds.
Dr. Cooper explains what the WHO’s move really means for patients, why long-term treatment matters, and how policy decisions in places like California and India could reshape who actually benefits from
info_outlineFat Science
This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor answer listener questions about BMI cutoffs, weight cycling, metabolic adaptation, trauma, GLP-1 differences, and why some people gain weight on ultra-low calories. Dr. Cooper explains what’s really happening inside the metabolic system and why individualized treatment—not dieting—creates sustainable change.
Key Questions Answered
- If my BMI doesn’t “qualify” for GLP-1s, is Na info_outline
Fat Science
Dr. Emily Cooper, Mark Wright, and Andrea Taylor talk with Maria from Buffalo, a longtime listener who shares her lifelong journey with obesity, psoriatic arthritis, and binge eating—and how finally understanding the science of metabolism gave her hope. Maria describes early childhood weight gain, joint damage, and years of restrictive dieting and food shame, then explains how GLP‑1 therapy (Zepbound) plus mechanical eating helped her lose about 50 pounds while eating more food, more often, and with
info_outlineThis week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor are joined by renowned childhood obesity expert Dr. Evan Nadler for a deep, honest conversation about what really is making our kids fat—and what’s finally changing about how kids, parents, and doctors can fight it.
The panel unpacks why the word “fat” is still so emotionally charged, how culture and even healthcare still get it wrong about weight, and why obesity must be recognized as a medical disease—not a moral failure. Dr. Nadler shares stories from two decades on the front lines, Dr. Cooper highlights transformative new science, and Andrea brings personal experience that challenges stereotypes and reveals the harm of shame-based approaches.
From the latest treatments—including medication and surgery for kids under 12—to the power of genetics, hormones, and family history, this episode breaks the silence, busts the myths, and lays out hope for families everywhere.
Key Takeaways:
- The global prevalence of childhood obesity keeps rising, with 15 million kids in the US now affected, and most will progress to adult obesity without intervention.
- Obesity in kids is driven by a complex web of biology—genes, prenatal health, and hormones—not “overeating” or lack of willpower.
- Parental health before and during pregnancy strongly affects a child’s risk of obesity, and interventions work best when started early—even before birth.
- Shame, strict dieting, and constant focus on weight do lifelong damage. Kids need support, not blame, and a focus on total health—sleep, nutrition, stress, and fun movement.
- New medications (like GLP-1 agonists) and bariatric surgery are safe, evidence-based options for select children, and can be life-changing when used correctly.
- Advances in science and patient care show that individualized treatment (not “one-size-fits-all” fixes) leads to the best long-term health and lower risk of serious complications in adulthood.
- There are always choices—kids and families should know they are not alone, and there are always next steps in medical care, whatever age or size a child may be.
Resources from the episode:Fat Science is dedicated to empowering families and changing the conversation about metabolism—reminding us all that fat isn’t a failure. For more resources, stories, and to submit a listener question, visit our website. If you are a healthcare professional and are interested in Dr Cooper’s upcoming training course, click on provider course at the Fat Science Podcast website!
If you have questions, a show idea, feedback, or want to connect, email us at questions@fatsciencepodcast.com or dr.c@fatsciencepodcast.com.
Connect with Dr. Emily Cooper on LinkedIn.Connect with Mark Wright on LinkedIn.Connect with Andrea Taylor on Instagram.
Connect with Dr. Evan Nadler on his website.
*This podcast is for informational purposes only and is not intended to replace professional medical advice.